Skip to main content
. 2015 May 8;15:374. doi: 10.1186/s12885-015-1363-1

Figure 3.

Figure 3

Sorafenib and everolimus effect on (A) ERM activation and (B) MES-MM98 cell migration; black line untreated cells, blue line everolimus 10nM, green line sorefenib 2.5 μM, and red line combination-treated cells.